Sort
51,570 grants matching “autoimmune disease”
The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes
$521,191Todd Michael Brusko · University Of Florida · R01 · FY2020 · DK
Novel mouse models to dissect the role of genetics, sex, and environment in heterogeneous outcomes in CNS autoimmune disease
$521,143Dimitry N Krementsov · University Of Vermont & St Agric College · R01 · FY2025 · AI
Novel mouse models to dissect the role of genetics, sex, and environment in heterogeneous outcomes in CNS autoimmune disease
$521,143Dimitry N Krementsov · University Of Vermont & St Agric College · R01 · FY2024 · AI
Novel mouse models to dissect the role of genetics, sex, and environment in heterogeneous outcomes in CNS autoimmune disease
$521,143Dimitry N Krementsov · University Of Vermont & St Agric College · R01 · FY2023 · AI
Mechanisms underlying regulation of injured axons in CNS autoimmunity
$521,130Chen Gu · Ohio State University · R01 · FY2024 · NS
Roles of non-Coding RNAs in Programming Lymphocyte Differentiation and Function
$521,101Stefan Muljo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Determinants of induced Treg and inflammatory Th17 cell balance in response to potentially pathogenic microbiota
$521,077Dan R Littman · New York University School Of Medicine · R01 · FY2023 · AI
Determinants of induced Treg and inflammatory Th17 cell balance in response to potentially pathogenic microbiota
$521,077Dan R Littman · New York University School Of Medicine · R01 · FY2022 · AI
Determinants of induced Treg and inflammatory Th17 cell balance in response to potentially pathogenic microbiota
$521,077Dan R Littman · New York University School Of Medicine · R01 · FY2021 · AI
Determinants of induced Treg and inflammatory Th17 cell balance in response to potentially pathogenic microbiota
$521,077Dan R Littman · New York University School Of Medicine · R01 · FY2024 · AI
Tolerogenic dual microparticle system for treatment of multiple sclerosis
$520,957Benjamin George Keselowsky · University Of Florida · R01 · FY2021 · AI
Tolerogenic dual microparticle system for treatment of multiple sclerosis
$520,957Benjamin George Keselowsky · University Of Florida · R01 · FY2018 · AI
Tolerogenic dual microparticle system for treatment of multiple sclerosis
$520,957Benjamin George Keselowsky · University Of Florida · R01 · FY2020 · AI
Tolerogenic dual microparticle system for treatment of multiple sclerosis
$520,957Benjamin George Keselowsky · University Of Florida · R01 · FY2017 · AI
Tolerogenic dual microparticle system for treatment of multiple sclerosis
$520,957Benjamin George Keselowsky · University Of Florida · R01 · FY2019 · AI
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction
$520,926Amy E Moran · Oregon Health & Science University · R37 · FY2024 · CA
Exploring the Fetal Origins Hypothesis in Diverse Youth
$520,925Dana Dabelea · University Of Colorado Denver · R01 · FY2007 · DK
Mechanisms of non-IgE Mast Cell Activation by Environmental Particulates
$520,820Jared Michael Brown · University Of Colorado Denver · R01 · FY2024 · ES
T-Cell Targeting for GVHD
$520,796Bruce R. Blazar · University Of Minnesota · R01 · FY2022 · HL
Conformal islet encapsulation for transplantation at vascularized sites to allow physiological insulin secretion
$520,751Alice Tomei · University Of Miami School Of Medicine · R01 · FY2024 · DK
Mechanism of Immunoglobulin Hypermutation
$520,729Ursula B Storb · University Of Chicago · R01 · FY2009 · AI
Novel Innate and Adaptive Immunity Pathways Lead to Human Systemic Autoimmunity
$520,613Maria Virginia Pascual · Weill Medical Coll Of Cornell Univ · U19 · FY2017 · AI
Role of Novel Inhibitory Pathways in Alloimmunity and Tolerance
$520,597Bruce R. Blazar · Harvard Medical School · P01 · FY2010 · AI
Harnessing NKT Cell Activation by Glycolipids
$520,591Amy R. Howell · University Of Connecticut Storrs · R01 · FY2020 · GM
Harnessing NKT Cell Activation by Glycolipids
$520,580Amy R. Howell · University Of Connecticut Storrs · U01 · FY2014 · GM